CIK 0001437402 · Large accelerated filer
ARDELYX, INC.
Sign in to watch- Ticker
- ARDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 510-745-7047
- Business address
- 34175 ARDENWOOD BLVD., FREMONT, CA, 94555
- Former names
- NTERYX INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $486,197
- in 8 filings
Net −$486,197. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- RAAB MICHAEL −$226K President & CEO sold 3% of stake
- Bishop John E −$76K See Remarks sold 6% of stake
- Brady James Parker −$58K Chief Human Resources Officer sold 6% of stake
- Williams Laura A −$41K Chief Patient Officer sold 3% of stake
- Foster Eric Duane −$33K Chief Commercial Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-20 | Foster Eric Duane Chief Commercial Officer | Sale | −1 | $5.71 | $6 | 425,971 |
| 2026-02-20 | Foster Eric Duane Chief Commercial Officer | Sale | −1 | $5.70 | $6 | 425,970 |
| 2026-01-23 | Reilly Joseph James See Remarks | Grant or award | +46,200 | 156,781 | ||
| 2026-01-23 | Reilly Joseph James See Remarks | Grant or award · Stock Option (Right to Buy) | +69,360 | 69,360 | ||
| 2026-01-23 | Kelliher Mike See Remarks | Grant or award | +103,080 | 374,261 | ||
| 2026-01-23 | Kelliher Mike See Remarks | Grant or award · Stock Option (Right to Buy) | +154,625 | 154,625 | ||
| 2026-01-23 | Hohenleitner Susan Chief Financial Officer | Grant or award | +85,670 | 232,566 | ||
| 2026-01-23 | Hohenleitner Susan Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +128,505 | 128,505 | ||
| 2026-01-23 | Foster Eric Duane Chief Commercial Officer | Grant or award | +137,945 | 436,409 | ||
| 2026-01-23 | Foster Eric Duane Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +206,915 | 206,915 | ||
| 2026-01-23 | RAAB MICHAEL President & CEO | Grant or award | +446,220 | 1,902,968 | ||
| 2026-01-23 | RAAB MICHAEL President & CEO | Grant or award · Stock Option (Right to Buy) | +669,330 | 669,330 | ||
| 2026-01-23 | Brady James Parker Chief Human Resources Officer | Grant or award | +99,455 | 265,455 | ||
| 2026-01-23 | Brady James Parker Chief Human Resources Officer | Grant or award · Stock Option (Right to Buy) | +149,185 | 149,185 | ||
| 2026-01-23 | Williams Laura A Chief Patient Officer | Grant or award | +82,695 | 444,258 | ||
| 2026-01-23 | Williams Laura A Chief Patient Officer | Grant or award · Stock Option (Right to Buy) | +124,040 | 124,040 | ||
| 2026-01-23 | Bishop John E See Remarks | Grant or award | +124,330 | 342,330 | ||
| 2026-01-23 | Bishop John E See Remarks | Grant or award · Stock Option (Right to Buy) | +186,500 | 186,500 | ||
| 2026-01-08 | Williams Laura A Chief Patient Officer | Option exercise 10b5-1 | +50,000 | $0.99 | $50K | 409,896 |
| 2026-01-08 | Williams Laura A Chief Patient Officer | Sale 10b5-1 | −50,000 | $6.98 | $349K | 361,563 |
Page 6 of 11 · 206 trades